To test this possibility, we knocked down PR in T47D breast cancer cells using the short-hairpin RNA approach (shPR) and analyzed PR and ESR1 gene expression by RT-qPCR and Western blotting assays. The gene discussed is PGR; the disease is breast carcinoma.